Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RXMD | Common Stock | Purchase | $15K | +468K | $0.03 | 468K | Dec 10, 2021 | Direct | F1 | |
transaction | RXMD | Common Stock | Purchase | $17K | +532K | +113.68% | $0.03 | 1M | Dec 13, 2021 | Direct | F1 |
Id | Content |
---|---|
F1 | The original Form 4 was filed on December 23, 2021. This amendment is being filed to correct an administrative error in reporting the amount of securities acquired and the amount of securities beneficially owned following reported transactions in Columns 4 and 5, respectively, in Table I. |
This Form 4 is being filed on a voluntary basis.